Comparison of Indocyanine Green with conventional tracers for sentinel lymph node biopsy in breast cancer: A multidisciplinary evaluation of clinical effectiveness, safety, organizational and economic impact.
Maria PinelliChiara GerardiEmanuele LettieriMadalina MaioruLaura MaroneLorenzo BertoldiGiuseppe NavanteriMaurizio CostantiniClaudio BottiFrancesca PelliniPublished in: PloS one (2024)
This study provided strong evidence for ICG's clinical and economic value for SLNB in breast cancer. It ascertained ICG as a valuable alternative to conventional tracers, ensuring clinical effectiveness along with economic and organizational benefits.